Astrazeneca AZN
NYSE AZN
$185.49 -1.27 (-0.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Astrazeneca (AZN) Free Cash Flow (2009 - 2025)

Updated

Astrazeneca (AZN) posted Free Cash Flow of $7.96 billion for Q3 2026, down 0.4% from $8 billion a year earlier but up 689.9% from the prior quarter.

Analysis

Astrazeneca (AZN) Free Cash Flow (2009 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Free Cash Flow at Astrazeneca was $10.63 billion, down 22.8% year-over-year; for FY2025, it came in at $11.77 billion, up 18.4% from FY2024.

  • Annual Free Cash Flow has increased for seven consecutive years, with a five-year compound annual growth rate of 25.1% (FY2020 to FY2025).
  • In prior years, Astrazeneca's Free Cash Flow was $9.94 billion in FY2024 (+10.6%), $8.98 billion in FY2023 (+3.1%), $8.72 billion in FY2022 (+78.9%) and $4.87 billion in FY2021 (+26.9%).
  • Quarterly Free Cash Flow has run from a low of -$2.24 billion in Q4 2025 to a high of $8 billion in Q3 2025 over five years.
  • On a year-over-year basis, Free Cash Flow has declined in each of the last three quarters, with growth averaging 6.4% over the last six quarters.
  • The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2022, with growth of 239.6%; the weakest was Q2 2026, with a decline of 46.1%.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was $1.01 billion (Q2 2026), $3.91 billion (Q1 2026) and -$2.24 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Yr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.97 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.70 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.36 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 17.60 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 11.77 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 8.10 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 9.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 9.08 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 3.19 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.77 Bn
Dec 31, 2024 9.94 Bn
Dec 31, 2023 8.98 Bn
Dec 31, 2022 8.72 Bn
Dec 31, 2021 4.87 Bn
Dec 31, 2020 3.84 Bn
Dec 31, 2019 1.99 Bn
Dec 31, 2018 1.58 Bn
Dec 31, 2017 2.25 Bn
Dec 31, 2016 2.70 Bn
Dec 31, 2015 2.00 Bn
Dec 31, 2014 8.07 Bn
Dec 31, 2013 8.14 Bn
Dec 31, 2012 7.62 Bn
Dec 31, 2011 8.66 Bn
Dec 31, 2010 11.47 Bn
Dec 31, 2009 12.70 Bn
API Access

Astrazeneca Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY